The historic 1st annual conference of the Israeli Society for Chemical and Biological Sensing (ISBCS) took place at the Institute of Nanotechnology and Advanced Materials at Bar Ilan University on February 13th.
The scientific committee for the conference was composed of Prof. Amos Danielli, from the Faculty of Engineering and the Institute of Nanotechnology and Advanced Materials at Bar Ilan University, Prof. Hadar Ben-Yoav, from Ben-Gurion University of the Negev, and Prof. Gili Bisker, from Tel Aviv University.
Generously sponsored by ILMAR and BioAnalytics Ltd, the conference brought together numerous biomedical researchers, as well as representatives from the Directorate of Defense Research and Development (DDR&D, MAFAT), the Israel Innovation Authority, and the Ministry of Innovation, Science, and Technology. The organizing committee expresses sincere gratitude to the distinguished speakers from prominent academic institutions across Israel: Prof. Ester Segal (Technion), Prof. Gil Shalev (Ben-Gurion University), Prof. Ariel Kushmaro (Ben-Gurion University), Dr. Zvi Yaari (Hebrew University), Prof. David Margulies (Weizmann Institute of Science), Prof. Rachela Popovtzer (Bar Ilan University), and Prof. Ramez Daniel (Technion).
The committee also extends its thanks to the 40 students who participated in the poster competition, showcasing their research contributions.
As part of the program, the attendees had the opportunity to learn about some of the ongoing research in our Optical Imaging and Biosensing laboratory, presented by our Biological Lab Manager, Dr. Linoy Golani-Zaidie, and our Ph.D. students, Shmuel Burg and Sophie Terenteva, who shared their latest research through three different posters.
On January 26th, our M.Sc. student, Sophie Terenteva—who is currently continuing her research in our lab as a Ph.D. student—presented her research work at the Novel Nanomaterial-Based Sensors session of the BIOS: Frontiers in Biological Detection: From Nanosensors to Systems XVII conference, held during the SPIE Photonics West 2025 convention in San Francisco, USA. Our principal investigator, Prof. Amos Danielli, served as a co-chair of the BIOS conference.
In her lecture, Ms. Terenteva discussed the development of highly sensitive anti-NS1 DENV-1–3 IgG assays using optical modulation biosensing technology. She presented the analytical and clinical performances of the dengue serological assay across different serotypes, along with its cross-reactivity with other flaviviruses such as WNV, JEV, and ZIKV.
Congratulations to our Ph.D. student, Shmuel Burg, for his significant achievement as the first author of a recently published book chapter in IntechOpen, alongside our alumnus Dr. Michael Margulis and Prof. Amos Danielli, the head of the Optical Imaging and Biosensing Lab.
The chapter, titled 'From Concept to Commercialization: High-Throughput Optical Modulation Biosensing for Detecting Low Concentrations of Biomarkers', provides a comprehensive review of the innovative Optical Modulation Biosensing (OMB) technology, detailing its development from the initial Magnetic Modulation Biosensing (MMB) concept to its commercialization as the automated OMBi device. The work highlights its application in the rapid and highly sensitive detection of proteins (e.g., human Interleukin-8) and viruses (e.g., SARS-CoV-2).
The chapter is available in the Publications section or via DOI: 10.5772/intechopen.1008860.
Prof. Danielli specializes in Electro-optics and Bio-photonics. After completing his Bachelor’s and Master’s degrees in the field of optical communication at Tel Aviv University, he worked in industry for eight years and then return to the Academy. During his studies for P.hD, he developed a new technology to rapidly detect fluorescent-labeled probes at very low concentrations in homogenous solutions and continued developing it during his post-doctoral studies in Washington University, St. Louis.
In 2014, he has returned to Israel and joined the faculty of Engineering at Bar Ilan University.
During his stay in the US, he founded a company that commercializes this technology, and established connections with key figures in the fields of medical laboratory and diagnostics, and especially among troponin and heart attack specialists.
We are always happy to hear from postdocs and students at all levels (BSc., MSc. and PhD.) with various backgrounds (mathematics, engineering, physics, biology) who are interested by the kind of research we are doing. send an email to Amos.danielli2@gmail.com
